Gilead Sciences, Inc.'s Form 4 filing
Assembly Biosciences, Inc. (ASMB) · filed Dec 23, 2024
- Accession no.
- 0000904454-24-000669
- Filed
- Dec 23, 2024
- Trade date
- Dec 19, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $20.1M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gilead Sciences, Inc.CIK 0000882095 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Common Stock | PPurchaseAcquired | +940,499 | $21.37 | +$20,098,463.63 | 2,209,471 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.